BioCentury
ARTICLE | Targets & Mechanisms

Meeting the burden

New developments in TMB, synthetic lethality, oncolytic viruses & more at AACR18

April 13, 2018 3:45 AM UTC

A major theme at this year’s AACR is the abundance of preclinical discovery driven by molecular signatures in patient samples, suggesting the research community is heeding the call for studies better grounded in human data, and for new ways to develop the right treatments for the right patients.

That’s one of the key findings of BioCentury’s third annual analysis of the meeting abstracts, which records 87 new and emerging targets, 39 new synthetic lethal interactions, and expanded interest in oncolytic viruses, cell therapies and other new modalities. ...